Figure 4
|
AT
|
BE
|
BG
|
CY
|
CZ
|
DE
|
DK
|
EE
|
ES
|
FI
|
FR
|
GR
|
HR
|
HU
|
IE
|
IT
|
LT
|
LU
|
LV
|
MT
|
NL
|
PL
|
PT
|
RO
|
SE
|
SI
|
SK
|
UK
|
|
EU 28
|
WHO Europe
|
|
AL
|
AM
|
AZ
|
BA
|
BY
|
CH
|
GE
|
IL
|
IS
|
KG
|
KZ
|
MD
|
ME
|
MK
|
NO
|
RS
|
RU
|
TJ
|
TM
|
TR
|
UA
|
UZ
|
Sarcoidosis
|
10.7
|
4.6
|
|
0.5
|
3.9
|
|
5.3
|
|
1.1
|
3.7
|
|
|
3.6
|
|
|
2.0
|
2.4
|
3.8
|
1.1
|
0.2
|
|
11.5
|
1.7
|
|
|
7.0
|
18.5
|
2.2
|
|
4.7
|
4.5
|
|
|
|
|
|
|
2.6
|
|
1.5
|
5.5
|
|
|
|
|
|
6.1
|
|
|
|
|
|
|
|
Extrinsic allergic alveolitis
|
3.5
|
1.8
|
|
|
0.5
|
|
0.5
|
|
0.9
|
0.7
|
|
|
0.2
|
|
|
0.6
|
0.2
|
4.1
|
0.2
|
0.4
|
|
0.8
|
0.7
|
|
|
0.8
|
1.7
|
0.6
|
|
1.1
|
0.9
|
|
|
|
|
|
|
0.5
|
|
0.1
|
0.9
|
|
|
|
|
|
0.3
|
|
|
|
|
|
|
|
Connective tissue disease
|
31.5
|
17.4
|
|
1.9
|
12.3
|
|
24.1
|
|
13.7
|
23.5
|
|
|
17.7
|
|
|
33.5
|
19.1
|
5.9
|
12.3
|
4.2
|
|
28.7
|
7.4
|
|
|
18.6
|
14.2
|
7.7
|
|
16.3
|
16.8
|
|
|
|
|
|
|
11.6
|
|
8.1
|
20.3
|
|
|
|
|
|
35.3
|
|
|
|
|
|
|
|
Idiopathic fibrosing alveolitis and other ILD
|
13.9
|
3.3
|
|
1.1
|
11.5
|
|
24.9
|
|
3.3
|
13.5
|
|
|
7.8
|
|
|
3.8
|
3.0
|
7.2
|
4.8
|
12.9
|
|
15.0
|
2.3
|
|
|
10.4
|
23.6
|
8.4
|
|
9.5
|
8.9
|
|
|
|
|
|
|
6.3
|
|
3.3
|
7.5
|
|
|
|
|
|
8.3
|
|
|
|
|
|
|
|
Figure 4
– Age-standardised annual hospital admissions (per 100 000) in the period 2005–2010 for the most important interstitial lung diseases (ILDs): sarcoidosis (International Classification of Disease (ICD)-10 code D86), chronic ILD (ICD-10 code J84; including idiopathic pulmonary fibrosis (IPF) and other forms of ILD), extrinsic allergic alveolitis (EAA) (ICD-10 code J67 ) and connective tissue disease (CTD) (ICD-10 code M32–M36). EU: European Union. Data from the World Health Organization (WHO) Hospital Morbidity Database, October 2011.
Download Raw Data
See the entire Interstitial lung diseases Chapter